èšåºæ®µéã®ãã€ãªãã¯ãããžãŒäŒæ¥ã§ãã Relmada Therapeutics, Inc. ã¯ãäžæ¢ç¥çµç³» (CNS) çŸæ£ããã®ä»ã®éå®³ã®æ²»çã®ããã®ããŸããŸãªè£œåã®éçºã«æ³šåããŠããŸããå瀟ã®äž»åããã°ã©ã 㯠REL-1017 ã§ãããã¯æäººã®å€§ãã€ç
æ§é害ã®è£å©çæ³ãŸãã¯åç¬çæ³ã®ããã®æ°ããååŠç©è³ªã§ãããæ°ãã N-ã¡ãã«-D-ã¢ã¹ãã©ã®ã³é
žå容äœãã£ãã«é®æè¬ã§ããå瀟㯠2004 幎ã«èšç«ããããããªãå·ã³ãŒã©ã«ã²ãŒãã«ãºã«æ ç¹ã眮ããŠããŸãã